Wave Life Sciences (WVE) Preferred Stock Liabilities (2016 - 2025)
Historic Preferred Stock Liabilities for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $7.9 million.
- Wave Life Sciences' Preferred Stock Liabilities changed 0.0% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.9 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Preferred Stock Liabilities is $7.9 million, which was down 0.0% from $7.9 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Preferred Stock Liabilities ranged from a high of $7.9 million in Q1 2021 and a low of $7.9 million during Q1 2021
- In the last 5 years, Wave Life Sciences' Preferred Stock Liabilities had a median value of $7.9 million in 2021 and averaged $7.9 million.
- Data for Wave Life Sciences' Preferred Stock Liabilities shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
- Wave Life Sciences' Preferred Stock Liabilities (Quarter) stood at $7.9 million in 2021, then changed by 0.0% to $7.9 million in 2022, then changed by 0.0% to $7.9 million in 2023, then changed by 0.0% to $7.9 million in 2024, then changed by 0.0% to $7.9 million in 2025.
- Its last three reported values are $7.9 million in Q3 2025, $7.9 million for Q2 2025, and $7.9 million during Q1 2025.